| Preferential release of newly synthesized prolactin granules is the result of functional heterogeneity among mammotrophs AM WALKER, MG FARQUHAR, B Peng Endocrinology 107 (4), 1095-1104, 1980 | 186 | 1980 |
| Development of recombinant human prolactin receptor antagonists by molecular mimicry of the phosphorylated hormone TJ Chen, CB Kuo, KF Tsai, JW Liu, DY Chen, AM Walker Endocrinology 139 (2), 609-616, 1998 | 149 | 1998 |
| Inaccuracies in MTS assays: major distorting effects of medium, serum albumin, and fatty acids KT Huang, YH Chen, AM Walker Biotechniques 37 (3), 406-412, 2004 | 138 | 2004 |
| Transcriptional changes underlying the secretory activation phase of mammary gland development MJ Naylor, SR Oakes, M Gardiner-Garden, J Harris, K Blazek, TWC Ho, ... Molecular Endocrinology 19 (7), 1868-1883, 2005 | 133 | 2005 |
| Phosphorylation of prolactin. WS Oetting, PT Tuazon, JA Traugh, AM Walker Journal of Biological Chemistry 261 (4), 1649-1652, 1986 | 127 | 1986 |
| Effects of prolactin on osteoblast alkaline phosphatase and bone formation in the developing rat D Coss, L Yang, CB Kuo, X Xu, RA Luben, AM Walker American Journal of Physiology-Endocrinology And Metabolism 279 (6), E1216-E1225, 2000 | 124 | 2000 |
| Central infusions of the recombinant human prolactin receptor antagonist, S179D-PRL, delay the onset of maternal behavior in steroid-primed, nulliparous female rats RS Bridges, BA Rigero, EM Byrnes, L Yang, AM Walker Endocrinology 142 (2), 730-739, 2001 | 107 | 2001 |
| Dephosphorylation of standard prolactin produces a more biologically active molecule: evidence for antagonism between nonphosphorylated and phosphorylated prolactin in the … YF Wang, AM Walker Endocrinology 133 (5), 2156-2160, 1993 | 102 | 1993 |
| Prolactin isoform 2 as an autocrine growth factor for GH3 cells KA Krown, YF Wang, TW Ho, PA Kelly, AM Walker Endocrinology 131 (2), 595-602, 1992 | 100 | 1992 |
| Calcium as a second messenger in the stimulation of luteinizing hormone secretion CR Hopkins, AM Walker Molecular and Cellular Endocrinology 12 (2), 189-208, 1978 | 99 | 1978 |
| A molecular mimic of phosphorylated prolactin markedly reduced tumor incidence and size when DU145 human prostate cancer cells were grown in nude mice X Xu, E Kreye, CB Kuo, AM Walker Cancer research 61 (16), 6098-6104, 2001 | 78 | 2001 |
| Unmodified prolactin (PRL) and S179D PRL-initiated bioluminescence resonance energy transfer between homo-and hetero-pairs of long and short human PRL receptors in living human … D Tan, DA Johnson, W Wu, L Zeng, YH Chen, WY Chen, BK Vonderhaar, ... Molecular Endocrinology 19 (5), 1291-1303, 2005 | 72 | 2005 |
| Inhibition of prolactin (PRL)-induced proliferative signals in breast cancer cells by a molecular mimic of phosphorylated PRL, S179D-PRL MD Schroeder, JL Brockman, AM Walker, LA Schuler Endocrinology 144 (12), 5300-5307, 2003 | 67 | 2003 |
| Different biological effects of unmodified prolactin and a molecular mimic of phosphorylated prolactin involve different signaling pathways W Wu, D Coss, MY Lorenson, CB Kuo, X Xu, AM Walker Biochemistry 42 (24), 7561-7570, 2003 | 65 | 2003 |
| Identification of the major site of rat prolactin phosphorylation as serine 177 YF Wang, JW Liu, M Mamidi, AM Walker Journal of Biological Chemistry 271 (5), 2462-2469, 1996 | 64 | 1996 |
| A molecular mimic demonstrates that phosphorylated human prolactin is a potent anti-angiogenic hormone E Ueda, U Ozerdem, YH Chen, M Yao, KT Huang, H Sun, ... Endocrine-related cancer 13 (1), 95-111, 2006 | 63 | 2006 |
| Maternal milk T cells drive development of transgenerational Th1 immunity in offspring thymus MK Ghosh, V Nguyen, HK Muller, AM Walker The Journal of Immunology 197 (6), 2290-2296, 2016 | 59 | 2016 |
| Mammotroph autoregulation: the differential roles of the 24K isoforms of prolactin TWC HO, JR GREENAN, AM WALKER Endocrinology 124 (3), 1507-1514, 1989 | 58 | 1989 |
| S179D prolactin increases vitamin D receptor and p21 through up-regulation of short 1b prolactin receptor in human prostate cancer cells W Wu, E Ginsburg, BK Vonderhaar, AM Walker Cancer research 65 (16), 7509-7515, 2005 | 56 | 2005 |
| Prolactin increases survival and migration of ovarian cancer cells: importance of prolactin receptor type and therapeutic potential of S179D and G129R receptor antagonists D Tan, KHE Chen, T Khoo, AM Walker Cancer letters 310 (1), 101-108, 2011 | 55 | 2011 |
